Alpha Omega Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Sell
123,122
-25,793
-17% -$2.3M 1.94% 8
2026
Q1
$10.7M Sell
148,915
-10
-0% -$770 1.73% 10
2025
Q4
$11.8M Sell
148,925
-977
-0.7% -$77K 1.96% 7
2025
Q3
$11.3M Buy
149,902
+16,418
+12% +$1.13M 1.88% 8
2025
Q2
$9.21M Sell
133,484
-15,435
-10% -$1.01M 1.65% 13
2025
Q1
$10.1M Buy
148,919
+27,875
+23% +$1.67M 1.93% 8
2024
Q4
$5.43M Sell
121,044
-32,643
-21% -$1.83M 1.03% 23
2024
Q3
$9.66M Buy
153,687
+1,969
+1% +$115K 1.77% 9
2024
Q2
$8.96M Buy
151,718
+14,890
+11% +$931K 1.71% 9
2024
Q1
$10.9M Sell
136,828
-1,247
-0.9% -$95.3K 2.03% 6
2023
Q4
$10.9M Sell
138,075
-802
-0.6% -$57.1K 1.81% 6
2023
Q3
$9.7M Buy
138,877
+3,135
+2% +$222K 1.67% 6
2023
Q2
$9.38M Buy
135,742
+39,753
+41% +$2.83M 1.59% 6
2023
Q1
$7.13M Buy
95,989
+6,783
+8% +$569K 1.23% 15
2022
Q4
$8.31M Sell
89,206
-2,061
-2% -$199K 1.48% 10
2022
Q3
$8.7M Sell
91,267
-1,452
-2% -$144K 1.66% 8
2022
Q2
$8.59M Buy
92,719
+2,341
+3% +$228K 1.53% 9
2022
Q1
$9.15M Sell
90,378
-847
-0.9% -$89K 1.45% 11
2021
Q4
$9.61M Sell
91,225
-1,680
-2% -$155K 1.48% 9
2021
Q3
$7.88M Sell
92,905
-347
-0.4% -$29.1K 1.29% 13
2021
Q2
$7.78M Sell
93,252
-107
-0.1% -$8.76K 1.28% 13
2021
Q1
$7.02M Buy
93,359
+2,901
+3% +$211K 1.23% 13
2020
Q4
$6.18M Buy
90,458
+1,304
+1% +$84.8K 1.05% 13
2020
Q3
$5.21M Sell
89,154
-1,479
-2% -$92K 0.73% 13
2020
Q2
$5.89M Sell
90,633
-3,713
-4% -$234K 0.9% 6
2020
Q1
$5.6M Sell
94,346
-2,181
-2% -$146K 1.03% 7
2019
Q4
$7.17M Sell
96,527
-132
-0.1% -$9.27K 1.15% 7
2019
Q3
$7M Buy
96,659
+30,815
+47% +$1.83M 1.14% 7
2019
Q2
$3.59M Buy
65,844
+6,158
+10% +$332K 1.52% 20
2019
Q1
$3.22M Buy
59,686
+15,330
+35% +$946K 1.44% 26
2018
Q4
$2.91M Sell
44,356
-4,298
-9% -$321K 1.46% 24
2018
Q3
$3.83M Buy
48,654
+128
+0.3% +$9.15K 1.72% 22
2018
Q2
$3.12M Buy
48,526
+3,229
+7% +$213K 1.53% 25
2018
Q1
$2.82M Buy
45,297
+1,268
+3% +$91K 1.41% 30
2017
Q4
$3.19M Buy
44,029
+7,922
+22% +$576K 1.56% 28
2017
Q3
$2.94M Buy
36,107
+916
+3% +$72.5K 1.46% 28
2017
Q2
$2.83M Buy
35,191
+2,066
+6% +$163K 1.45% 31
2017
Q1
$2.6M Buy
33,125
+2,245
+7% +$179K 1.39% 29
2016
Q4
$2.44M Buy
30,880
+767
+3% +$62.1K 1.29% 31
2016
Q3
$2.68M Buy
30,113
+957
+3% +$90.3K 2.13% 19
2016
Q2
$2.79M Sell
29,156
-173
-0.6% -$17.2K 2.36% 12
2016
Q1
$3.04M Sell
29,329
-83
-0.3% -$8.07K 2.54% 6
2015
Q4
$2.88M Buy
+29,412
New +$2.88M 2.52% 7

Other funds holding CVS

Alpha Omega Wealth Management's CVS Position: Q2 2026 in Review

Alpha Omega Wealth Management reduced its CVS Health (CVS) stake by 17% in Q2 2026, selling an estimated $2.3M and leaving 123,122 shares worth $12.7M. The position accounts for 1.94% of the portfolio, ranked #8.

Alpha Omega Wealth Management first reported a position in CVS in Q4 2015 and has held it in 43 quarters since. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Alpha Omega Wealth Management held 123,122 shares of CVS Health worth $12.7M as of Q2 2026.
  • Alpha Omega Wealth Management sold 25,793 CVS Health shares in Q2 2026, an estimated $2.3M.
  • CVS Health made up 1.94% of Alpha Omega Wealth Management's portfolio in Q2 2026, its #8 holding.
  • Alpha Omega Wealth Management first reported a position in CVS Health in Q4 2015 and has held it in 43 quarters since.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Alpha Omega Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.